Vidac Pharma Ltd.

Actinic keratosis and precancerous skin lesions

The sponsor’s clinical research is centered on dermatologic disease, with a specific focus on actinic keratosis, a common sun-related premalignant skin lesion. Its work reflects interest in lesions that require careful evaluation for early intervention and monitoring of treatment response.

  • Actinic keratosis
  • Precancerous cutaneous lesions
  • Dermatologic oncology

Research activity in this area highlights treatment development for visible skin lesions managed in outpatient dermatology settings.

Topical dermatologic therapy

The sponsor is involved in research on topical treatment approaches for skin disease, including ointment-based therapy designed for localized application to affected lesions. This therapeutic area is relevant to non-invasive management of superficial dermatologic conditions.

  • Topical ointments
  • Localized skin treatment
  • Non-systemic dermatologic therapy

The clinical focus remains on therapies intended for direct application to lesion sites in patients with sun-damaged skin.

Skin lesion assessment and imaging

Clinical interest also extends to the evaluation of lesion change using advanced skin imaging and microscopic assessment tools. This supports investigation of how treated lesions respond over time in dermatology practice.

  • Line-field confocal optical coherence tomography
  • Marker lesion evaluation
  • Cutaneous imaging biomarkers

These interests align with research focused on objective monitoring of visible skin abnormalities during treatment.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of Tuvatexib Ointment Compared to Placebo for Patients with Actinic Keratosis

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Germany